It is very uncertain whether systemic antibiotics plus antibiotic lock solutions plus tissue… changes cure: long‐term success compared with systemic antibiotics plus antibiotic lock solutions plus heparin (very low certainty).

1 finding from 1 review

Interventions for treating catheter‐related bloodstream infections in people receiving maintenance haemodialysis 2022 · Cochrane Headline outcomes only
RR 64 [0.38, 1.06]
18 participants
Very low

Systemic antibiotics plus antibiotic lock solutions plus tissue plasminogen activator vs systemic antibiotics plus antibiotic lock solutions plus heparin

Cure: infection‐free survival · patients on maintenance HD with CRBSI

1 finding from 1 review

Interventions for treating catheter‐related bloodstream infections in people receiving maintenance haemodialysis 2022 · Cochrane Headline outcomes only
no estimate extracted
18 participants
Very low

Systemic antibiotics plus antibiotic lock solutions plus tissue plasminogen activator vs systemic antibiotics plus antibiotic lock solutions plus heparin

Stenosis or thrombosis of vascular access site after catheter removal · patients on maintenance HD with CRBSI

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for treating catheter‐related bloodstream infections in people receiving maintenance haemodialysis 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Systemic antibiotics plus antibiotic lock solutions plus tissue plasminogen activator vs systemic antibiotics plus antibiotic lock solutions plus heparin

Death · patients on maintenance HD with CRBSI

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for treating catheter‐related bloodstream infections in people receiving maintenance haemodialysis 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Systemic antibiotics plus antibiotic lock solutions plus tissue plasminogen activator vs systemic antibiotics plus antibiotic lock solutions plus heparin

Development of antibiotic resistance · patients on maintenance HD with CRBSI

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for treating catheter‐related bloodstream infections in people receiving maintenance haemodialysis 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Systemic antibiotics plus antibiotic lock solutions plus tissue plasminogen activator vs systemic antibiotics plus antibiotic lock solutions plus heparin

Adverse effects · patients on maintenance HD with CRBSI

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for treating catheter‐related bloodstream infections in people receiving maintenance haemodialysis 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Systemic antibiotics alone vs systematic antibiotics plus antibiotic lock solution

Cure: successful eradication of the infection · patients on maintenance HD with CRBSI

It is very uncertain whether systemic antibiotics alone changes cure: successful eradication of the infection compared with systematic antibiotics plus antibiotic lock solution (very low certainty).

1 finding from 1 review

Interventions for treating catheter‐related bloodstream infections in people receiving maintenance haemodialysis 2022 · Cochrane Headline outcomes only
RR 1.61 [1.16, 2.23]
1 study · 64 participants
Very low

Systemic antibiotics alone vs systematic antibiotics plus antibiotic lock solution

Stenosis or thrombosis of vascular access site after catheter removal · patients on maintenance HD with CRBSI

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for treating catheter‐related bloodstream infections in people receiving maintenance haemodialysis 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Registration behaviour: ICC adjusted (dichotomous) · increasing solid organ donation registration

The intervention may leads to higher registration behaviour: ICC adjusted (dichotomous) (low certainty).

1 finding from 1 review

Interventions for increasing solid organ donor registration 2021 · Cochrane Headline outcomes only
RR 1.3 [1.19, 1.43]
16 studies · 1294065 participants
Low

Intervention not reported

Registration intention (dichotomous) · increasing solid organ donation registration intention

The intervention may leads to higher registration intention (dichotomous) (low certainty).

1 finding from 1 review

Interventions for increasing solid organ donor registration 2021 · Cochrane Headline outcomes only
RR 1.21 [1.03, 1.42]
10 studies · 10838 participants
Low

Intervention not reported

Registration intention: ICC adjusted (continuous) · increasing solid organ donor registration

1 finding from 1 review

Interventions for increasing solid organ donor registration 2021 · Cochrane Headline outcomes only
no estimate extracted
9 studies · 3572 participants
Low

Heparin vs placebo

Early graft thrombosis · kidney transplant recipients

1 finding from 1 review

Interventions for preventing thrombosis in solid organ transplant recipients 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Very low

Heparin vs placebo

Major bleeding events: unfractionated heparin · kidney transplant recipients

Heparin showed no clear difference in major bleeding events: unfractionated heparin compared with placebo (low certainty).

1 finding from 1 review

Interventions for preventing thrombosis in solid organ transplant recipients 2021 · Cochrane Headline outcomes only
RR 2.92 [0.89, 9.56]
3 studies · 155 participants
Low

Heparin vs placebo

Major bleeding events: all heparin · kidney transplant recipients

Heparin showed no clear difference in major bleeding events: all heparin compared with placebo (low certainty).

1 finding from 1 review

Interventions for preventing thrombosis in solid organ transplant recipients 2021 · Cochrane Headline outcomes only
RR 2.7 [0.89, 8.19]
3 studies · 180 participants
Low

Heparin vs placebo

Readmissions to intensive care: all heparin · kidney transplant recipients

It is very uncertain whether heparin changes readmissions to intensive care: all heparin compared with placebo (very low certainty).

1 finding from 1 review

Interventions for preventing thrombosis in solid organ transplant recipients 2021 · Cochrane Headline outcomes only
RR 0.68 [0.12, 3.9]
3 studies · 180 participants
Very low

Heparin vs placebo

Blood transfusion requirements · kidney transplant recipients

1 finding from 1 review

Interventions for preventing thrombosis in solid organ transplant recipients 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Very low

Heparin vs placebo

Graft and patient survival · kidney transplant recipients

1 finding from 1 review

Interventions for preventing thrombosis in solid organ transplant recipients 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Very low